| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalic Acids | 44 | 2024 | 485 | 4.590 |
Why?
|
| Environmental Pollutants | 55 | 2024 | 1291 | 4.470 |
Why?
|
| Pregnancy Complications, Infectious | 51 | 2024 | 2187 | 4.170 |
Why?
|
| Infectious Disease Transmission, Vertical | 46 | 2023 | 1354 | 4.170 |
Why?
|
| HIV Infections | 146 | 2024 | 17533 | 3.970 |
Why?
|
| Anti-Retroviral Agents | 34 | 2024 | 1787 | 3.390 |
Why?
|
| Phenols | 26 | 2024 | 522 | 2.650 |
Why?
|
| Anti-HIV Agents | 41 | 2024 | 4559 | 2.050 |
Why?
|
| Maternal Exposure | 26 | 2024 | 1096 | 2.050 |
Why?
|
| Semen | 14 | 2023 | 354 | 1.990 |
Why?
|
| Parabens | 17 | 2023 | 117 | 1.980 |
Why?
|
| Pregnancy | 188 | 2024 | 30258 | 1.820 |
Why?
|
| Antiretroviral Therapy, Highly Active | 32 | 2020 | 1899 | 1.670 |
Why?
|
| Lead | 9 | 2022 | 879 | 1.660 |
Why?
|
| Polychlorinated Biphenyls | 16 | 2022 | 234 | 1.610 |
Why?
|
| Reproductive Techniques, Assisted | 20 | 2022 | 504 | 1.590 |
Why?
|
| Fertilization in Vitro | 30 | 2020 | 1307 | 1.590 |
Why?
|
| Semen Analysis | 18 | 2023 | 237 | 1.580 |
Why?
|
| Environmental Exposure | 48 | 2024 | 4543 | 1.560 |
Why?
|
| Infertility, Female | 17 | 2023 | 763 | 1.500 |
Why?
|
| Prenatal Exposure Delayed Effects | 25 | 2023 | 2531 | 1.460 |
Why?
|
| Paternal Exposure | 12 | 2023 | 101 | 1.430 |
Why?
|
| Diethylhexyl Phthalate | 10 | 2023 | 86 | 1.420 |
Why?
|
| Infertility | 16 | 2022 | 656 | 1.410 |
Why?
|
| Premature Birth | 22 | 2023 | 1829 | 1.360 |
Why?
|
| Dioxins | 12 | 2022 | 91 | 1.320 |
Why?
|
| Puberty | 13 | 2022 | 491 | 1.310 |
Why?
|
| Benzhydryl Compounds | 19 | 2024 | 939 | 1.300 |
Why?
|
| Pregnancy Outcome | 31 | 2024 | 2967 | 1.280 |
Why?
|
| Acquired Immunodeficiency Syndrome | 12 | 2023 | 2203 | 1.240 |
Why?
|
| HIV | 9 | 2022 | 1585 | 1.180 |
Why?
|
| Sexual Maturation | 7 | 2019 | 246 | 1.150 |
Why?
|
| Endocrine Disruptors | 10 | 2024 | 249 | 1.090 |
Why?
|
| Prospective Studies | 139 | 2024 | 54806 | 1.040 |
Why?
|
| Abnormalities, Drug-Induced | 7 | 2024 | 335 | 1.000 |
Why?
|
| Russia | 26 | 2022 | 383 | 0.950 |
Why?
|
| Live Birth | 15 | 2021 | 518 | 0.940 |
Why?
|
| Infertility, Male | 10 | 2019 | 395 | 0.920 |
Why?
|
| Flame Retardants | 7 | 2020 | 97 | 0.880 |
Why?
|
| Female | 312 | 2024 | 396101 | 0.830 |
Why?
|
| Sperm Count | 13 | 2023 | 227 | 0.810 |
Why?
|
| Child | 132 | 2024 | 80563 | 0.790 |
Why?
|
| Abortion, Spontaneous | 9 | 2020 | 536 | 0.770 |
Why?
|
| Maternal-Fetal Exchange | 9 | 2018 | 453 | 0.720 |
Why?
|
| Puberty, Delayed | 2 | 2013 | 124 | 0.720 |
Why?
|
| Child Development | 16 | 2020 | 2327 | 0.720 |
Why?
|
| Adolescent | 134 | 2024 | 88832 | 0.720 |
Why?
|
| Humans | 385 | 2024 | 765956 | 0.720 |
Why?
|
| Models, Statistical | 6 | 2023 | 5089 | 0.710 |
Why?
|
| Adult | 197 | 2024 | 223038 | 0.680 |
Why?
|
| Infant, Newborn | 60 | 2024 | 26349 | 0.650 |
Why?
|
| Hydrocarbons, Chlorinated | 7 | 2020 | 120 | 0.650 |
Why?
|
| CD4 Lymphocyte Count | 24 | 2021 | 2587 | 0.630 |
Why?
|
| Microcephaly | 2 | 2020 | 426 | 0.630 |
Why?
|
| Cohort Studies | 82 | 2023 | 41647 | 0.620 |
Why?
|
| Ovarian Follicle | 7 | 2023 | 243 | 0.620 |
Why?
|
| Reproduction | 12 | 2021 | 641 | 0.610 |
Why?
|
| Young Adult | 100 | 2024 | 59886 | 0.610 |
Why?
|
| HIV-1 | 17 | 2022 | 6944 | 0.600 |
Why?
|
| Viral Load | 22 | 2022 | 3386 | 0.600 |
Why?
|
| Spermatozoa | 8 | 2019 | 629 | 0.590 |
Why?
|
| Fertility | 11 | 2021 | 768 | 0.590 |
Why?
|
| Cosmetics | 4 | 2023 | 103 | 0.580 |
Why?
|
| Pregnancy Trimester, First | 11 | 2024 | 920 | 0.580 |
Why?
|
| Environmental Health | 8 | 2018 | 297 | 0.580 |
Why?
|
| Pesticides | 8 | 2020 | 296 | 0.580 |
Why?
|
| Sperm Motility | 10 | 2023 | 265 | 0.580 |
Why?
|
| Reverse Transcriptase Inhibitors | 10 | 2022 | 618 | 0.560 |
Why?
|
| Male | 214 | 2024 | 363691 | 0.560 |
Why?
|
| Adolescent Development | 3 | 2018 | 275 | 0.550 |
Why?
|
| Birth Weight | 8 | 2023 | 2122 | 0.550 |
Why?
|
| Pesticide Residues | 4 | 2018 | 96 | 0.540 |
Why?
|
| Mercury | 4 | 2022 | 291 | 0.540 |
Why?
|
| HIV Protease Inhibitors | 6 | 2022 | 430 | 0.520 |
Why?
|
| Meningococcal Vaccines | 5 | 2017 | 96 | 0.510 |
Why?
|
| Follicle Stimulating Hormone | 9 | 2023 | 731 | 0.500 |
Why?
|
| Leiomyoma | 4 | 2021 | 643 | 0.500 |
Why?
|
| Language Disorders | 2 | 2016 | 140 | 0.490 |
Why?
|
| Fetal Development | 5 | 2023 | 777 | 0.480 |
Why?
|
| Halogenated Diphenyl Ethers | 4 | 2024 | 84 | 0.480 |
Why?
|
| Infant | 47 | 2024 | 36385 | 0.480 |
Why?
|
| Epidemiologic Research Design | 1 | 2018 | 368 | 0.480 |
Why?
|
| Triclosan | 4 | 2019 | 59 | 0.480 |
Why?
|
| Zidovudine | 6 | 2023 | 626 | 0.470 |
Why?
|
| Pregnancy Rate | 11 | 2020 | 655 | 0.470 |
Why?
|
| Maternal Age | 6 | 2019 | 804 | 0.450 |
Why?
|
| Risk Assessment | 27 | 2021 | 24283 | 0.450 |
Why?
|
| Folic Acid | 6 | 2019 | 1339 | 0.440 |
Why?
|
| Longitudinal Studies | 32 | 2024 | 14749 | 0.430 |
Why?
|
| Anti-Mullerian Hormone | 5 | 2023 | 420 | 0.430 |
Why?
|
| Mental Disorders | 11 | 2018 | 6851 | 0.420 |
Why?
|
| Bayes Theorem | 14 | 2024 | 2354 | 0.420 |
Why?
|
| Preconception Care | 4 | 2019 | 143 | 0.410 |
Why?
|
| Prenatal Injuries | 1 | 2012 | 13 | 0.400 |
Why?
|
| Child Behavior | 4 | 2023 | 865 | 0.400 |
Why?
|
| Infant Mortality | 4 | 2022 | 751 | 0.390 |
Why?
|
| Stillbirth | 5 | 2023 | 381 | 0.390 |
Why?
|
| AIDS-Related Opportunistic Infections | 6 | 2015 | 664 | 0.390 |
Why?
|
| Blood Glucose | 9 | 2024 | 6425 | 0.390 |
Why?
|
| Diabetes, Gestational | 6 | 2022 | 1264 | 0.390 |
Why?
|
| Pregnancy Trimester, Second | 9 | 2021 | 738 | 0.390 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2009 | 61 | 0.390 |
Why?
|
| Benzoxazines | 4 | 2019 | 320 | 0.380 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 5 | 2015 | 87 | 0.380 |
Why?
|
| Cluster Analysis | 1 | 2018 | 2720 | 0.380 |
Why?
|
| Language Tests | 1 | 2012 | 191 | 0.380 |
Why?
|
| Perimenopause | 2 | 2024 | 142 | 0.370 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 4 | 2016 | 395 | 0.370 |
Why?
|
| Benzophenones | 3 | 2020 | 58 | 0.370 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 2686 | 0.370 |
Why?
|
| Child, Preschool | 41 | 2023 | 42500 | 0.360 |
Why?
|
| Carbanilides | 2 | 2021 | 18 | 0.350 |
Why?
|
| Seafood | 4 | 2018 | 395 | 0.350 |
Why?
|
| RNA, Viral | 9 | 2015 | 2864 | 0.350 |
Why?
|
| Pregnancy Trimesters | 3 | 2023 | 198 | 0.340 |
Why?
|
| Meningococcal Infections | 4 | 2017 | 78 | 0.340 |
Why?
|
| Government Agencies | 7 | 2002 | 161 | 0.340 |
Why?
|
| Risk Factors | 55 | 2021 | 74836 | 0.340 |
Why?
|
| Infant, Low Birth Weight | 7 | 2023 | 871 | 0.340 |
Why?
|
| Fruit | 5 | 2019 | 1167 | 0.340 |
Why?
|
| Vegetables | 5 | 2019 | 1200 | 0.330 |
Why?
|
| Preservatives, Pharmaceutical | 3 | 2015 | 34 | 0.330 |
Why?
|
| Cross-Sectional Studies | 38 | 2023 | 26313 | 0.330 |
Why?
|
| Feeding Behavior | 8 | 2024 | 3211 | 0.330 |
Why?
|
| United States | 64 | 2024 | 72898 | 0.320 |
Why?
|
| Birth Order | 3 | 2019 | 93 | 0.320 |
Why?
|
| Air Pollutants | 7 | 2021 | 2923 | 0.320 |
Why?
|
| Massachusetts | 22 | 2020 | 8871 | 0.310 |
Why?
|
| Nervous System | 3 | 2018 | 542 | 0.310 |
Why?
|
| Medication Adherence | 4 | 2019 | 2190 | 0.300 |
Why?
|
| Puerto Rico | 7 | 2019 | 381 | 0.300 |
Why?
|
| Oocytes | 5 | 2020 | 1169 | 0.300 |
Why?
|
| Trophoblasts | 1 | 2010 | 223 | 0.300 |
Why?
|
| Sulfones | 3 | 2021 | 447 | 0.300 |
Why?
|
| Plasticizers | 9 | 2019 | 52 | 0.300 |
Why?
|
| Survival Analysis | 3 | 2017 | 10070 | 0.290 |
Why?
|
| Dairy Products | 3 | 2017 | 491 | 0.290 |
Why?
|
| beta Carotene | 2 | 2019 | 522 | 0.290 |
Why?
|
| Hexachlorobenzene | 4 | 2015 | 26 | 0.290 |
Why?
|
| Furans | 5 | 2021 | 198 | 0.290 |
Why?
|
| Spinal Dysraphism | 2 | 2020 | 179 | 0.290 |
Why?
|
| Placenta | 3 | 2017 | 1728 | 0.290 |
Why?
|
| Linear Models | 20 | 2019 | 5876 | 0.290 |
Why?
|
| Models, Theoretical | 2 | 2019 | 3564 | 0.290 |
Why?
|
| Alkynes | 4 | 2019 | 326 | 0.290 |
Why?
|
| Embryo Implantation | 6 | 2016 | 271 | 0.290 |
Why?
|
| Lead Poisoning | 1 | 2010 | 318 | 0.280 |
Why?
|
| Substance-Related Disorders | 4 | 2017 | 4415 | 0.280 |
Why?
|
| Vaccines, Conjugate | 5 | 2017 | 334 | 0.270 |
Why?
|
| Cyclopropanes | 4 | 2019 | 437 | 0.270 |
Why?
|
| Self Report | 11 | 2019 | 3771 | 0.270 |
Why?
|
| Sexual Behavior | 4 | 2021 | 2193 | 0.270 |
Why?
|
| Eating | 4 | 2018 | 1539 | 0.270 |
Why?
|
| Environmental Monitoring | 11 | 2018 | 1470 | 0.270 |
Why?
|
| Memory Disorders | 4 | 2017 | 1194 | 0.270 |
Why?
|
| Dietary Supplements | 8 | 2020 | 3426 | 0.260 |
Why?
|
| Fishes | 4 | 2018 | 606 | 0.260 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 2067 | 0.260 |
Why?
|
| Metals | 4 | 2022 | 710 | 0.260 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 261 | 0.250 |
Why?
|
| Executive Function | 4 | 2023 | 1391 | 0.250 |
Why?
|
| Patient Dropouts | 1 | 2008 | 410 | 0.250 |
Why?
|
| Soy Foods | 2 | 2016 | 44 | 0.240 |
Why?
|
| Observation | 1 | 2007 | 309 | 0.240 |
Why?
|
| Triglycerides | 4 | 2022 | 2441 | 0.240 |
Why?
|
| Boston | 18 | 2024 | 9338 | 0.240 |
Why?
|
| Fluorocarbons | 2 | 2020 | 497 | 0.240 |
Why?
|
| Body Mass Index | 16 | 2022 | 13039 | 0.240 |
Why?
|
| Cognition Disorders | 6 | 2016 | 3967 | 0.240 |
Why?
|
| Sperm Injections, Intracytoplasmic | 4 | 2019 | 157 | 0.240 |
Why?
|
| Diet | 13 | 2019 | 8086 | 0.230 |
Why?
|
| Steroids | 1 | 2010 | 933 | 0.230 |
Why?
|
| Language Development Disorders | 2 | 2018 | 194 | 0.230 |
Why?
|
| Botswana | 7 | 2023 | 1057 | 0.230 |
Why?
|
| Pregnancy Complications | 8 | 2020 | 2971 | 0.230 |
Why?
|
| Patient Participation | 1 | 2013 | 1454 | 0.220 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 770 | 0.220 |
Why?
|
| Meat Products | 2 | 2014 | 97 | 0.220 |
Why?
|
| Soaps | 2 | 2023 | 30 | 0.220 |
Why?
|
| Cognition | 8 | 2020 | 7048 | 0.220 |
Why?
|
| Follicular Fluid | 2 | 2021 | 92 | 0.220 |
Why?
|
| Fetal Weight | 1 | 2023 | 90 | 0.210 |
Why?
|
| Aromatase | 3 | 2017 | 147 | 0.210 |
Why?
|
| Drug Therapy, Combination | 11 | 2018 | 6309 | 0.210 |
Why?
|
| HIV Seropositivity | 4 | 2013 | 961 | 0.210 |
Why?
|
| Caprylates | 2 | 2020 | 114 | 0.210 |
Why?
|
| Congenital Abnormalities | 4 | 2024 | 704 | 0.210 |
Why?
|
| Delivery, Obstetric | 3 | 2019 | 946 | 0.210 |
Why?
|
| Age Factors | 16 | 2020 | 18380 | 0.200 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 5 | 2003 | 82 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 1774 | 0.200 |
Why?
|
| Hair | 2 | 2017 | 508 | 0.200 |
Why?
|
| Dietary Proteins | 2 | 2018 | 959 | 0.200 |
Why?
|
| Thyroid Gland | 2 | 2020 | 1180 | 0.200 |
Why?
|
| Vehicle Emissions | 3 | 2018 | 651 | 0.200 |
Why?
|
| Pharmaceutical Services | 2 | 2019 | 145 | 0.200 |
Why?
|
| Hypercholesterolemia | 5 | 2018 | 1149 | 0.200 |
Why?
|
| Particulate Matter | 4 | 2021 | 2624 | 0.200 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.200 |
Why?
|
| Lamivudine | 3 | 2019 | 368 | 0.190 |
Why?
|
| Antibodies, Bacterial | 6 | 2017 | 1476 | 0.190 |
Why?
|
| Mothers | 6 | 2021 | 2208 | 0.190 |
Why?
|
| Hot Flashes | 2 | 2022 | 330 | 0.190 |
Why?
|
| Prevalence | 13 | 2024 | 15839 | 0.190 |
Why?
|
| Hearing Loss | 2 | 2023 | 784 | 0.180 |
Why?
|
| Patient Selection | 1 | 2013 | 4255 | 0.180 |
Why?
|
| HIV Seronegativity | 4 | 2019 | 209 | 0.180 |
Why?
|
| Adolescent Behavior | 2 | 2021 | 1185 | 0.180 |
Why?
|
| Cholesterol | 4 | 2022 | 2898 | 0.180 |
Why?
|
| Intelligence | 3 | 2014 | 923 | 0.180 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 15651 | 0.180 |
Why?
|
| Embryo Transfer | 3 | 2020 | 525 | 0.180 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.180 |
Why?
|
| Coronary Disease | 3 | 2019 | 5912 | 0.180 |
Why?
|
| Logistic Models | 11 | 2019 | 13266 | 0.180 |
Why?
|
| Mental Health | 2 | 2024 | 3272 | 0.180 |
Why?
|
| Fathers | 2 | 2023 | 377 | 0.180 |
Why?
|
| Fluoxetine | 1 | 2004 | 729 | 0.170 |
Why?
|
| Anencephaly | 1 | 2020 | 20 | 0.170 |
Why?
|
| Waist Circumference | 3 | 2022 | 933 | 0.170 |
Why?
|
| Didanosine | 1 | 2020 | 151 | 0.170 |
Why?
|
| Occupational Exposure | 5 | 2017 | 1805 | 0.170 |
Why?
|
| Menarche | 1 | 2023 | 532 | 0.170 |
Why?
|
| Severity of Illness Index | 13 | 2018 | 15880 | 0.170 |
Why?
|
| Oxazines | 1 | 2022 | 358 | 0.170 |
Why?
|
| Arsenic | 2 | 2022 | 356 | 0.170 |
Why?
|
| Serologic Tests | 2 | 2022 | 382 | 0.170 |
Why?
|
| Body Composition | 2 | 2019 | 2439 | 0.170 |
Why?
|
| Middle Aged | 56 | 2024 | 223004 | 0.170 |
Why?
|
| Proportional Hazards Models | 13 | 2021 | 12509 | 0.170 |
Why?
|
| Postpartum Period | 3 | 2024 | 1203 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2008 | 2692 | 0.170 |
Why?
|
| Michigan | 4 | 2021 | 328 | 0.170 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2022 | 295 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2017 | 469 | 0.160 |
Why?
|
| Luteinizing Hormone | 1 | 2022 | 826 | 0.160 |
Why?
|
| Sample Size | 1 | 2023 | 845 | 0.160 |
Why?
|
| Body Height | 6 | 2017 | 1562 | 0.160 |
Why?
|
| Oocyte Retrieval | 2 | 2020 | 163 | 0.160 |
Why?
|
| Carnitine | 2 | 2022 | 253 | 0.160 |
Why?
|
| BCG Vaccine | 1 | 2022 | 380 | 0.160 |
Why?
|
| Diet Surveys | 6 | 2019 | 1159 | 0.160 |
Why?
|
| Household Products | 1 | 2019 | 26 | 0.160 |
Why?
|
| Condoms | 1 | 2021 | 336 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2004 | 587 | 0.160 |
Why?
|
| Electromagnetic Fields | 1 | 2020 | 290 | 0.150 |
Why?
|
| Fertility Agents | 1 | 2018 | 11 | 0.150 |
Why?
|
| Thyrotropin | 2 | 2020 | 841 | 0.150 |
Why?
|
| Birth Intervals | 1 | 2018 | 54 | 0.150 |
Why?
|
| Viremia | 2 | 2022 | 727 | 0.150 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 138 | 0.150 |
Why?
|
| Exercise | 3 | 2021 | 5937 | 0.150 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2018 | 44 | 0.150 |
Why?
|
| Body Size | 2 | 2012 | 459 | 0.150 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 148 | 0.150 |
Why?
|
| Trace Elements | 1 | 2019 | 193 | 0.150 |
Why?
|
| Follow-Up Studies | 19 | 2021 | 39194 | 0.150 |
Why?
|
| Diet, Mediterranean | 3 | 2020 | 746 | 0.150 |
Why?
|
| DEET | 1 | 2017 | 11 | 0.150 |
Why?
|
| Treatment Outcome | 25 | 2022 | 65189 | 0.150 |
Why?
|
| Ozone | 2 | 2020 | 499 | 0.150 |
Why?
|
| Clothing | 1 | 2018 | 95 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2022 | 550 | 0.150 |
Why?
|
| Estradiol | 5 | 2024 | 1947 | 0.150 |
Why?
|
| Causality | 4 | 2022 | 1248 | 0.150 |
Why?
|
| Amiloride | 1 | 2017 | 115 | 0.150 |
Why?
|
| Incidence | 18 | 2021 | 21480 | 0.140 |
Why?
|
| Embryo Culture Techniques | 1 | 2018 | 84 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2022 | 580 | 0.140 |
Why?
|
| Ventricular Function, Left | 3 | 2016 | 3928 | 0.140 |
Why?
|
| Minerals | 1 | 2019 | 278 | 0.140 |
Why?
|
| Pyrethrins | 1 | 2017 | 47 | 0.140 |
Why?
|
| Reproductive Medicine | 1 | 2019 | 97 | 0.140 |
Why?
|
| Noise | 1 | 2020 | 296 | 0.140 |
Why?
|
| Reproductive History | 1 | 2018 | 210 | 0.140 |
Why?
|
| Pregnancy, Ectopic | 1 | 2018 | 146 | 0.140 |
Why?
|
| Air Pollution | 3 | 2020 | 2380 | 0.140 |
Why?
|
| Product Packaging | 1 | 2017 | 26 | 0.140 |
Why?
|
| Adenine | 2 | 2013 | 994 | 0.140 |
Why?
|
| Ovulation Induction | 5 | 2019 | 277 | 0.140 |
Why?
|
| Pyridones | 1 | 2022 | 816 | 0.140 |
Why?
|
| Infant Formula | 1 | 2018 | 192 | 0.140 |
Why?
|
| Copper | 1 | 2019 | 367 | 0.140 |
Why?
|
| Parity | 4 | 2021 | 931 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 532 | 0.140 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 1261 | 0.140 |
Why?
|
| Odds Ratio | 12 | 2019 | 9649 | 0.140 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 24 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 357 | 0.140 |
Why?
|
| Ovary | 3 | 2023 | 956 | 0.140 |
Why?
|
| Micronutrients | 1 | 2020 | 390 | 0.130 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 1660 | 0.130 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2016 | 38 | 0.130 |
Why?
|
| Lifting | 1 | 2017 | 56 | 0.130 |
Why?
|
| Neuropsychological Tests | 9 | 2017 | 7122 | 0.130 |
Why?
|
| Echocardiography | 6 | 2019 | 5045 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 657 | 0.130 |
Why?
|
| Dicarboxylic Acids | 1 | 2016 | 75 | 0.130 |
Why?
|
| Gels | 1 | 2017 | 419 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 6014 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 2 | 2019 | 836 | 0.130 |
Why?
|
| Spouses | 1 | 2018 | 288 | 0.130 |
Why?
|
| Inflammation | 4 | 2023 | 10850 | 0.130 |
Why?
|
| Drug Synergism | 2 | 2018 | 1749 | 0.130 |
Why?
|
| Socioeconomic Factors | 6 | 2015 | 7836 | 0.130 |
Why?
|
| Sex Factors | 8 | 2022 | 10602 | 0.130 |
Why?
|
| Fetus | 2 | 2020 | 1878 | 0.130 |
Why?
|
| Hypolipidemic Agents | 2 | 2011 | 608 | 0.120 |
Why?
|
| Obesity, Abdominal | 1 | 2019 | 370 | 0.120 |
Why?
|
| Testosterone | 4 | 2024 | 2494 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2016 | 139 | 0.120 |
Why?
|
| Calcifediol | 1 | 2016 | 156 | 0.120 |
Why?
|
| Growth | 2 | 2010 | 365 | 0.120 |
Why?
|
| Urine | 2 | 2015 | 360 | 0.120 |
Why?
|
| Fuel Oils | 2 | 2005 | 36 | 0.120 |
Why?
|
| Twins | 2 | 2009 | 341 | 0.120 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2015 | 49 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 1811 | 0.120 |
Why?
|
| Meconium | 1 | 2015 | 47 | 0.120 |
Why?
|
| Radio Waves | 1 | 2016 | 246 | 0.120 |
Why?
|
| Insulin Resistance | 3 | 2019 | 3985 | 0.120 |
Why?
|
| Electric Impedance | 1 | 2019 | 794 | 0.120 |
Why?
|
| Testis | 1 | 2018 | 780 | 0.120 |
Why?
|
| Blastocyst | 1 | 2018 | 432 | 0.120 |
Why?
|
| Speech Perception | 1 | 2020 | 512 | 0.120 |
Why?
|
| C-Reactive Protein | 6 | 2023 | 3850 | 0.120 |
Why?
|
| Medicaid | 5 | 2015 | 2831 | 0.120 |
Why?
|
| Immunization, Secondary | 1 | 2017 | 373 | 0.120 |
Why?
|
| Georgia | 1 | 2015 | 186 | 0.120 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 4247 | 0.120 |
Why?
|
| Antioxidants | 2 | 2019 | 1670 | 0.110 |
Why?
|
| Computer Simulation | 2 | 2018 | 6255 | 0.110 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2015 | 139 | 0.110 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.110 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.110 |
Why?
|
| Fetal Diseases | 1 | 2020 | 914 | 0.110 |
Why?
|
| Diphtheria Toxoid | 2 | 2012 | 25 | 0.110 |
Why?
|
| Autoimmunity | 2 | 2020 | 1354 | 0.110 |
Why?
|
| Periodontitis | 3 | 2011 | 576 | 0.110 |
Why?
|
| Norway | 3 | 2020 | 499 | 0.110 |
Why?
|
| Language Development | 1 | 2015 | 183 | 0.110 |
Why?
|
| Prenatal Care | 2 | 2019 | 1159 | 0.110 |
Why?
|
| Quality of Life | 5 | 2023 | 13461 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2016 | 2136 | 0.110 |
Why?
|
| Gestational Age | 7 | 2021 | 3613 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 781 | 0.110 |
Why?
|
| Refusal to Participate | 1 | 2013 | 30 | 0.110 |
Why?
|
| Benzofurans | 2 | 2011 | 140 | 0.110 |
Why?
|
| Psychometrics | 3 | 2018 | 3062 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2077 | 0.110 |
Why?
|
| Embryonic Development | 1 | 2018 | 718 | 0.110 |
Why?
|
| AIDS Dementia Complex | 2 | 2015 | 154 | 0.110 |
Why?
|
| Autoantibodies | 2 | 2018 | 2113 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2019 | 2243 | 0.100 |
Why?
|
| Granulosa Cells | 1 | 2013 | 120 | 0.100 |
Why?
|
| Behavior | 1 | 2016 | 535 | 0.100 |
Why?
|
| Menopause | 1 | 2021 | 1659 | 0.100 |
Why?
|
| Tanzania | 3 | 2022 | 1407 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 554 | 0.100 |
Why?
|
| Drug Utilization | 3 | 2014 | 1187 | 0.100 |
Why?
|
| Dideoxynucleosides | 1 | 2013 | 135 | 0.100 |
Why?
|
| Food Preservatives | 1 | 2012 | 11 | 0.100 |
Why?
|
| Epidemiologic Methods | 4 | 2013 | 1326 | 0.100 |
Why?
|
| Air Pollutants, Occupational | 2 | 2005 | 406 | 0.100 |
Why?
|
| Lymphopenia | 1 | 2015 | 297 | 0.100 |
Why?
|
| Antidepressive Agents | 3 | 2013 | 2897 | 0.100 |
Why?
|
| Child of Impaired Parents | 2 | 2013 | 462 | 0.100 |
Why?
|
| Dibutyl Phthalate | 2 | 2022 | 29 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2021 | 1421 | 0.100 |
Why?
|
| Head | 1 | 2018 | 925 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 532 | 0.100 |
Why?
|
| Meat | 1 | 2015 | 588 | 0.100 |
Why?
|
| Life Style | 3 | 2019 | 3926 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2022 | 1192 | 0.100 |
Why?
|
| Time Factors | 11 | 2020 | 40065 | 0.100 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2013 | 197 | 0.100 |
Why?
|
| Multivariate Analysis | 9 | 2019 | 12057 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 1396 | 0.100 |
Why?
|
| Obesity | 6 | 2024 | 13075 | 0.100 |
Why?
|
| Caffeine | 1 | 2016 | 702 | 0.100 |
Why?
|
| Piperazines | 1 | 2022 | 2549 | 0.100 |
Why?
|
| Brain | 5 | 2023 | 27178 | 0.100 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 394 | 0.100 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2011 | 116 | 0.090 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2024 | 705 | 0.090 |
Why?
|
| Case-Control Studies | 13 | 2020 | 22222 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2019 | 4405 | 0.090 |
Why?
|
| Liver Failure | 1 | 2013 | 252 | 0.090 |
Why?
|
| Glucose | 2 | 2021 | 4335 | 0.090 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2017 | 667 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2017 | 483 | 0.090 |
Why?
|
| Cytokines | 2 | 2024 | 7421 | 0.090 |
Why?
|
| Women's Health | 4 | 2024 | 2084 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 3 | 2016 | 1166 | 0.090 |
Why?
|
| Inhalation Exposure | 2 | 2005 | 432 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2739 | 0.090 |
Why?
|
| No-Observed-Adverse-Effect Level | 7 | 2002 | 25 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 894 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 348 | 0.090 |
Why?
|
| Air Pollution, Indoor | 2 | 2013 | 931 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2011 | 163 | 0.090 |
Why?
|
| Breast Feeding | 4 | 2023 | 1363 | 0.090 |
Why?
|
| Insulin | 2 | 2023 | 6599 | 0.090 |
Why?
|
| Nucleosides | 1 | 2011 | 130 | 0.090 |
Why?
|
| Regression Analysis | 7 | 2017 | 6321 | 0.090 |
Why?
|
| Periodontal Diseases | 2 | 2004 | 453 | 0.090 |
Why?
|
| Cleft Lip | 2 | 2007 | 512 | 0.090 |
Why?
|
| Cleft Palate | 2 | 2007 | 592 | 0.080 |
Why?
|
| Neisseria meningitidis, Serogroup Y | 3 | 2017 | 3 | 0.080 |
Why?
|
| Neisseria meningitidis, Serogroup W-135 | 3 | 2017 | 3 | 0.080 |
Why?
|
| Neisseria meningitidis, Serogroup A | 3 | 2017 | 6 | 0.080 |
Why?
|
| Neisseria meningitidis, Serogroup C | 3 | 2017 | 11 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2013 | 559 | 0.080 |
Why?
|
| Dietary Fats | 2 | 2016 | 2002 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2015 | 1192 | 0.080 |
Why?
|
| Postpartum Hemorrhage | 1 | 2013 | 276 | 0.080 |
Why?
|
| Wechsler Scales | 3 | 2015 | 255 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 586 | 0.080 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2009 | 34 | 0.080 |
Why?
|
| Peer Group | 2 | 2012 | 701 | 0.080 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 11501 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 587 | 0.080 |
Why?
|
| Tooth Diseases | 1 | 2009 | 73 | 0.080 |
Why?
|
| Caregivers | 3 | 2017 | 2307 | 0.080 |
Why?
|
| Residence Characteristics | 2 | 2018 | 2115 | 0.080 |
Why?
|
| Vanadium | 2 | 2005 | 54 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2019 | 2554 | 0.080 |
Why?
|
| Alcohol-Related Disorders | 1 | 2011 | 242 | 0.080 |
Why?
|
| Occupational Diseases | 1 | 2017 | 1456 | 0.080 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 464 | 0.080 |
Why?
|
| Alveolar Bone Loss | 3 | 2008 | 394 | 0.080 |
Why?
|
| Ritonavir | 2 | 2022 | 330 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2015 | 1472 | 0.080 |
Why?
|
| Cattle | 1 | 2014 | 3801 | 0.080 |
Why?
|
| Government Programs | 7 | 2002 | 278 | 0.080 |
Why?
|
| Mycobacterium avium Complex | 3 | 2003 | 66 | 0.080 |
Why?
|
| Progesterone | 2 | 2024 | 752 | 0.070 |
Why?
|
| Welding | 2 | 2005 | 89 | 0.070 |
Why?
|
| Epidemiologic Studies | 2 | 2018 | 677 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2011 | 578 | 0.070 |
Why?
|
| Herpesvirus 3, Human | 1 | 2009 | 159 | 0.070 |
Why?
|
| Body Weights and Measures | 1 | 2008 | 208 | 0.070 |
Why?
|
| Dental Care | 1 | 2011 | 286 | 0.070 |
Why?
|
| South Africa | 2 | 2023 | 1867 | 0.070 |
Why?
|
| Psychotropic Drugs | 2 | 2012 | 879 | 0.070 |
Why?
|
| Memory | 1 | 2017 | 2190 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 246 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2016 | 1303 | 0.070 |
Why?
|
| Hypertension | 3 | 2022 | 8626 | 0.070 |
Why?
|
| Diseases in Twins | 1 | 2009 | 448 | 0.070 |
Why?
|
| Power Plants | 2 | 2005 | 125 | 0.070 |
Why?
|
| Nutrition Assessment | 3 | 2015 | 738 | 0.070 |
Why?
|
| Body Weight | 6 | 2017 | 4622 | 0.070 |
Why?
|
| Mouth Diseases | 1 | 2009 | 240 | 0.070 |
Why?
|
| Cholesterol, LDL | 3 | 2019 | 2393 | 0.070 |
Why?
|
| Registries | 6 | 2020 | 8297 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 1348 | 0.070 |
Why?
|
| Arsenic Poisoning | 1 | 2007 | 55 | 0.070 |
Why?
|
| Diet Records | 2 | 2020 | 425 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 99 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2013 | 1128 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2009 | 240 | 0.070 |
Why?
|
| Birth Rate | 2 | 2019 | 169 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4241 | 0.070 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 2736 | 0.070 |
Why?
|
| Research Design | 3 | 2024 | 6208 | 0.070 |
Why?
|
| Lactic Acid | 1 | 2011 | 1137 | 0.070 |
Why?
|
| Affective Symptoms | 1 | 2009 | 417 | 0.070 |
Why?
|
| Maxillary Diseases | 1 | 2006 | 46 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1662 | 0.070 |
Why?
|
| Herpes Zoster | 1 | 2009 | 252 | 0.070 |
Why?
|
| Bone Density | 1 | 2019 | 3491 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2017 | 12769 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1884 | 0.060 |
Why?
|
| Fertilization | 2 | 2018 | 197 | 0.060 |
Why?
|
| Comorbidity | 3 | 2022 | 10563 | 0.060 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 316 | 0.060 |
Why?
|
| Confidence Intervals | 4 | 2014 | 2910 | 0.060 |
Why?
|
| Resuscitation Orders | 1 | 2008 | 275 | 0.060 |
Why?
|
| Mannose-Binding Lectin | 1 | 2007 | 146 | 0.060 |
Why?
|
| Spermatogenesis | 2 | 2019 | 260 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7599 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 2660 | 0.060 |
Why?
|
| Serum Bactericidal Antibody Assay | 2 | 2017 | 2 | 0.060 |
Why?
|
| Public Health | 1 | 2018 | 2680 | 0.060 |
Why?
|
| Mandibular Diseases | 1 | 2006 | 117 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3229 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1936 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2023 | 8733 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 990 | 0.060 |
Why?
|
| Weight Gain | 3 | 2022 | 2355 | 0.060 |
Why?
|
| Chemical Industry | 1 | 2005 | 115 | 0.060 |
Why?
|
| Endometrium | 2 | 2019 | 406 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2010 | 1021 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 562 | 0.060 |
Why?
|
| Beverages | 2 | 2022 | 819 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2016 | 3832 | 0.060 |
Why?
|
| Animals | 19 | 2022 | 168759 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2018 | 4424 | 0.050 |
Why?
|
| Ethambutol | 1 | 2003 | 59 | 0.050 |
Why?
|
| Rifabutin | 1 | 2003 | 52 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2009 | 884 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2012 | 2020 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2013 | 1597 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2003 | 87 | 0.050 |
Why?
|
| Poisson Distribution | 2 | 2017 | 508 | 0.050 |
Why?
|
| Pyridines | 1 | 2015 | 2888 | 0.050 |
Why?
|
| Androgen Antagonists | 2 | 2022 | 1411 | 0.050 |
Why?
|
| Procarbazine | 1 | 2022 | 172 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 1217 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2019 | 790 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2003 | 190 | 0.050 |
Why?
|
| Gasoline | 1 | 2022 | 49 | 0.050 |
Why?
|
| Vaccination | 3 | 2022 | 3426 | 0.050 |
Why?
|
| New York | 2 | 2016 | 880 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2018 | 3718 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2014 | 6203 | 0.050 |
Why?
|
| Educational Status | 3 | 2014 | 2513 | 0.050 |
Why?
|
| Health Surveys | 2 | 2010 | 4056 | 0.050 |
Why?
|
| Drug Administration Schedule | 3 | 2018 | 4850 | 0.050 |
Why?
|
| Academic Medical Centers | 3 | 2019 | 2780 | 0.050 |
Why?
|
| Teratogens | 1 | 2002 | 121 | 0.050 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 14652 | 0.050 |
Why?
|
| Nutrition Surveys | 2 | 2019 | 1741 | 0.050 |
Why?
|
| Receptors, CCR | 1 | 2021 | 37 | 0.050 |
Why?
|
| Pharmacoepidemiology | 1 | 2005 | 351 | 0.050 |
Why?
|
| Nitrogen Dioxide | 2 | 2020 | 538 | 0.050 |
Why?
|
| Overweight | 2 | 2023 | 2443 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6598 | 0.050 |
Why?
|
| Population Surveillance | 3 | 2020 | 2590 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 52 | 0.050 |
Why?
|
| Cadmium | 1 | 2022 | 218 | 0.050 |
Why?
|
| Phenol | 1 | 2021 | 45 | 0.050 |
Why?
|
| Hospice Care | 1 | 2008 | 678 | 0.050 |
Why?
|
| Perinatal Care | 2 | 2014 | 243 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 396 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2024 | 1180 | 0.050 |
Why?
|
| Ghana | 1 | 2022 | 333 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 20125 | 0.040 |
Why?
|
| Time | 2 | 2016 | 550 | 0.040 |
Why?
|
| Troponin T | 2 | 2018 | 785 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 939 | 0.040 |
Why?
|
| Family Characteristics | 2 | 2016 | 1001 | 0.040 |
Why?
|
| Heart Rate | 2 | 2002 | 4203 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 36532 | 0.040 |
Why?
|
| Intelligence Tests | 2 | 2014 | 504 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7425 | 0.040 |
Why?
|
| Safe Sex | 1 | 2021 | 144 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6069 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2021 | 221 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 67 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2005 | 568 | 0.040 |
Why?
|
| Organ Size | 2 | 2017 | 2261 | 0.040 |
Why?
|
| Microbial Viability | 2 | 2012 | 235 | 0.040 |
Why?
|
| Molybdenum | 1 | 2019 | 45 | 0.040 |
Why?
|
| Sweetening Agents | 1 | 2022 | 291 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2010 | 3561 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2005 | 2352 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2005 | 3251 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 83 | 0.040 |
Why?
|
| Particle Size | 4 | 2005 | 1631 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 12240 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2023 | 3222 | 0.040 |
Why?
|
| Antipsychotic Agents | 2 | 2009 | 3074 | 0.040 |
Why?
|
| Uganda | 1 | 2024 | 1353 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10729 | 0.040 |
Why?
|
| Cause of Death | 1 | 2010 | 3708 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 746 | 0.040 |
Why?
|
| Vitamin A | 1 | 2022 | 610 | 0.040 |
Why?
|
| Hearing | 1 | 2023 | 505 | 0.040 |
Why?
|
| Quinolones | 1 | 2022 | 387 | 0.040 |
Why?
|
| Body Burden | 1 | 2019 | 156 | 0.040 |
Why?
|
| Self Concept | 2 | 2018 | 1037 | 0.040 |
Why?
|
| Sweden | 3 | 2009 | 1381 | 0.040 |
Why?
|
| Anthropometry | 2 | 2019 | 1338 | 0.040 |
Why?
|
| Personality Assessment | 2 | 2012 | 646 | 0.040 |
Why?
|
| Demography | 2 | 2018 | 1641 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 297 | 0.040 |
Why?
|
| Sterilization, Tubal | 1 | 2018 | 78 | 0.040 |
Why?
|
| Women | 1 | 2020 | 226 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 13631 | 0.040 |
Why?
|
| Thyroglobulin | 1 | 2018 | 112 | 0.040 |
Why?
|
| Selection Bias | 1 | 2020 | 361 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4427 | 0.040 |
Why?
|
| Insect Repellents | 1 | 2017 | 18 | 0.040 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 199 | 0.040 |
Why?
|
| Chlamydiaceae Infections | 1 | 2017 | 2 | 0.040 |
Why?
|
| Parturition | 1 | 2022 | 453 | 0.040 |
Why?
|
| Algorithms | 3 | 2019 | 14071 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 239 | 0.040 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2017 | 16 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 305 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2018 | 293 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2020 | 2122 | 0.040 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2017 | 28 | 0.040 |
Why?
|
| Mitochondria | 1 | 2011 | 3673 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2017 | 30 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1059 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2020 | 351 | 0.030 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2017 | 95 | 0.030 |
Why?
|
| Pharmacies | 1 | 2019 | 171 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 410 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2024 | 1369 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2018 | 115 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2018 | 1736 | 0.030 |
Why?
|
| Polypropylenes | 1 | 2017 | 63 | 0.030 |
Why?
|
| Serum | 1 | 2018 | 206 | 0.030 |
Why?
|
| Kenya | 1 | 2019 | 758 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 706 | 0.030 |
Why?
|
| Glass | 1 | 2017 | 116 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9747 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2002 | 644 | 0.030 |
Why?
|
| Cities | 1 | 2019 | 543 | 0.030 |
Why?
|
| Alcohol Drinking | 3 | 2019 | 4040 | 0.030 |
Why?
|
| Gene Expression | 3 | 2017 | 7584 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2018 | 496 | 0.030 |
Why?
|
| Plastics | 1 | 2017 | 117 | 0.030 |
Why?
|
| Selenium | 1 | 2019 | 419 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2021 | 543 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 2218 | 0.030 |
Why?
|
| Culture Media | 1 | 2018 | 890 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2020 | 575 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2016 | 59 | 0.030 |
Why?
|
| Ecosystem | 1 | 2020 | 488 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 718 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 558 | 0.030 |
Why?
|
| Phosphates | 1 | 2019 | 763 | 0.030 |
Why?
|
| Indoles | 1 | 2003 | 1839 | 0.030 |
Why?
|
| Poultry | 1 | 2015 | 79 | 0.030 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1885 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2018 | 1701 | 0.030 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Zinc | 1 | 2019 | 675 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
| Carbonated Beverages | 1 | 2016 | 209 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81515 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 751 | 0.030 |
Why?
|
| Premenopause | 1 | 2019 | 1037 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5077 | 0.030 |
Why?
|
| Food Handling | 1 | 2015 | 158 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 290 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 222 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 951 | 0.030 |
Why?
|
| Thyroxine | 1 | 2018 | 672 | 0.030 |
Why?
|
| Androstanes | 1 | 2014 | 20 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2015 | 193 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2019 | 804 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 1828 | 0.030 |
Why?
|
| Radiography | 3 | 2015 | 6919 | 0.030 |
Why?
|
| Tennessee | 1 | 2014 | 123 | 0.030 |
Why?
|
| Shellfish | 1 | 2014 | 37 | 0.030 |
Why?
|
| Gonadotropins | 1 | 2015 | 240 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2016 | 415 | 0.030 |
Why?
|
| Rats | 7 | 2002 | 23707 | 0.030 |
Why?
|
| Seasons | 1 | 2020 | 1524 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2018 | 1134 | 0.030 |
Why?
|
| District of Columbia | 1 | 2014 | 159 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1019 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 2395 | 0.030 |
Why?
|
| Aging | 3 | 2021 | 8731 | 0.030 |
Why?
|
| Latin America | 1 | 2015 | 416 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 8230 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1707 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 80 | 0.030 |
Why?
|
| Urinalysis | 1 | 2015 | 368 | 0.030 |
Why?
|
| Speech | 1 | 2018 | 555 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 782 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 871 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2119 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 2013 | 43 | 0.030 |
Why?
|
| Smoking | 2 | 2013 | 9081 | 0.030 |
Why?
|
| Luminescence | 1 | 2013 | 110 | 0.030 |
Why?
|
| Palliative Care | 1 | 2008 | 3645 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 591 | 0.030 |
Why?
|
| Reference Values | 2 | 2014 | 4908 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 1270 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2019 | 1789 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 560 | 0.030 |
Why?
|
| Microglia | 1 | 2021 | 1372 | 0.020 |
Why?
|
| Anxiety, Separation | 1 | 2012 | 85 | 0.020 |
Why?
|
| Urban Health | 1 | 2015 | 530 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 1673 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5891 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11640 | 0.020 |
Why?
|
| Oral Health | 2 | 2011 | 493 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 1146 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2018 | 1433 | 0.020 |
Why?
|
| Neisseria meningitidis | 1 | 2012 | 111 | 0.020 |
Why?
|
| Coffee | 1 | 2016 | 593 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2020 | 1620 | 0.020 |
Why?
|
| DDT | 1 | 2011 | 33 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2017 | 5993 | 0.020 |
Why?
|
| Emotions | 1 | 2023 | 2763 | 0.020 |
Why?
|
| Audiometry | 1 | 2012 | 253 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 341 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 328 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2013 | 426 | 0.020 |
Why?
|
| Meiosis | 1 | 2013 | 326 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2858 | 0.020 |
Why?
|
| Medical Records | 1 | 2017 | 1409 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2023 | 1944 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1668 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2015 | 895 | 0.020 |
Why?
|
| Serotyping | 1 | 2012 | 330 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2880 | 0.020 |
Why?
|
| Geography | 1 | 2013 | 652 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2003 | 3050 | 0.020 |
Why?
|
| Papillomavirus Vaccines | 1 | 2017 | 496 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2015 | 802 | 0.020 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 45 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2019 | 8067 | 0.020 |
Why?
|
| Rabbits | 1 | 2017 | 4734 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 851 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3141 | 0.020 |
Why?
|
| Periodontal Attachment Loss | 1 | 2011 | 151 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1984 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2017 | 1375 | 0.020 |
Why?
|
| Milk | 1 | 2013 | 436 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 308 | 0.020 |
Why?
|
| Periodontal Pocket | 1 | 2011 | 174 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2011 | 188 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 355 | 0.020 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2012 | 307 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1890 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 29921 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 578 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 171114 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 433 | 0.020 |
Why?
|
| Education, Special | 1 | 2010 | 86 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2009 | 47 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2009 | 54 | 0.020 |
Why?
|
| Breech Presentation | 1 | 2009 | 38 | 0.020 |
Why?
|
| Urban Population | 1 | 2017 | 2040 | 0.020 |
Why?
|
| Decision Trees | 1 | 2011 | 509 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 687 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1526 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 955 | 0.020 |
Why?
|
| Sick Role | 1 | 2009 | 229 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 578 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 10383 | 0.020 |
Why?
|
| Vitamins | 1 | 2016 | 1630 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2003 | 7478 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3312 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 855 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 935 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3819 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3316 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 986 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 5849 | 0.020 |
Why?
|
| Social Environment | 1 | 2012 | 1011 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 59488 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2022 | 6610 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2011 | 345 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 297 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23600 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 1638 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2643 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2009 | 633 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 1596 | 0.020 |
Why?
|
| Calcium | 1 | 2019 | 5767 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9591 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4642 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3710 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1652 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2005 | 12 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2505 | 0.020 |
Why?
|
| Water Supply | 1 | 2007 | 204 | 0.020 |
Why?
|
| Social Stigma | 1 | 2012 | 788 | 0.020 |
Why?
|
| Vitamin D | 1 | 2019 | 3272 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2845 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5929 | 0.020 |
Why?
|
| Respiratory Protective Devices | 1 | 2005 | 47 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1640 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 869 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2014 | 1546 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 1 | 2005 | 64 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3888 | 0.020 |
Why?
|
| Stavudine | 1 | 2005 | 85 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18071 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2008 | 675 | 0.010 |
Why?
|
| Awareness | 1 | 2009 | 653 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 2416 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2007 | 471 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
| Hepatitis A Antibodies | 1 | 2003 | 19 | 0.010 |
Why?
|
| Mumps virus | 1 | 2003 | 21 | 0.010 |
Why?
|
| Hepatitis A Vaccines | 1 | 2003 | 26 | 0.010 |
Why?
|
| Mortality | 1 | 2015 | 2904 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 1857 | 0.010 |
Why?
|
| Genital Neoplasms, Female | 1 | 2009 | 533 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4348 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8532 | 0.010 |
Why?
|
| Mice | 7 | 2002 | 81818 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 2003 | 188 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1999 | 8041 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3620 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2003 | 87 | 0.010 |
Why?
|
| Population | 1 | 2003 | 140 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2008 | 1072 | 0.010 |
Why?
|
| Azithromycin | 1 | 2003 | 201 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 2004 | 306 | 0.010 |
Why?
|
| Tooth Loss | 1 | 2004 | 198 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12807 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4562 | 0.010 |
Why?
|
| Recurrence | 2 | 2005 | 8501 | 0.010 |
Why?
|
| Forecasting | 1 | 2011 | 2936 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 10033 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1659 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5125 | 0.010 |
Why?
|
| India | 1 | 2007 | 2334 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2005 | 12437 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2009 | 1431 | 0.010 |
Why?
|
| Siblings | 1 | 2004 | 828 | 0.010 |
Why?
|
| Veterans | 1 | 2013 | 2664 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3624 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2002 | 582 | 0.010 |
Why?
|
| Housing | 1 | 2004 | 683 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3209 | 0.010 |
Why?
|
| Social Class | 1 | 2008 | 2007 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2108 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2002 | 878 | 0.010 |
Why?
|
| Health Status | 1 | 2011 | 4080 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6499 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2002 | 1530 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 1069 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 3318 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 5369 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 4808 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3425 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 2511 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 16047 | 0.010 |
Why?
|
| Sepsis | 1 | 2007 | 2606 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2007 | 5343 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 5302 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 13024 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2005 | 3800 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 11888 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 2821 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15398 | 0.000 |
Why?
|